The association of masked hypertension in treated type 2 diabetic patients with carotid artery IMT

Diabetes Research and Clinical Practice

Volumn 89, Issue 3, 2010, Pages 239-242

  Charvat, Jiri ^a   Chlumsky, Jaromir ^a   Szabo, Marcela ^a   Zakovicova, Eva ^a   Zamrazil, Vaclav ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Carotid distensibility; Carotid intima media thickness; Masked hypertension; Type 2 diabetes mellitus

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGE; ARTERIAL WALL THICKNESS; ARTERY COMPLIANCE; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CARDIOVASCULAR PARAMETERS; CIGARETTE SMOKING; COMMON CAROTID ARTERY; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; GENDER; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NON INSULIN DEPENDENT DIABETES MELLITUS;

EID: 77955429144     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.04.014     Document Type: Article

References (22)

1. Prospective Diabetes Study (UKPDS) Group U.K. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38. Br Med J 1996, 352:854-865.
2. Heart Outcome Prevention Evaluation Study Investigators: effects of ramipril on cardiovascular and microvascular outcome in people with diabetes mellitus: results of the HOPE study and MICROHOPE substudy. Lancet 2000, 355:253-259.
3. Clement D.L., De Buyzere M.L., De Bacquer D.A., de Leeuw P.W., Duprez D.A., Fagard R.H., et al. Prognostic value of ambulatory blood pressure recordings in patients with treated hypertension. N Engl J Med 2003, 348:2407-2415.
4. Pickering T.G., Davidson K., Gerin W., Schwartz J.E. Masked hypertension. Hypertension 2002, 40:795-796.
5. Liu J.E., Roman M.J., Pini R., Schwartz J.E., Pickering T.G., Deuereux R.B. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Arch Intern Med 1999, 131:564-572.
6. Sega R., Trocino G., Lanzarotti A., Carugo S., Cesana G., Schiavina R., et al. Alterations of cardiac structure in patients with isolated office, ambulatory or home hypertension. Data from the general population (PAMELA study). Circulation 2001, 104:1385-1392.
7. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., et al. The seventh Report of the Joint National Comittee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report. J Am Med Assoc 2003, 289:2560-2572.
8. Leitao C.B., Canani L.H., Kramer C.K., Boza J.C., Pinnoti A.F., Gross J.L. Masked hypertension, urinary albumin excretion rate, and echocardiographic parameters in putatively normotensive type 2 diabetic patients. Diabetes Care 2007, 30:1255-1260.
9. Strachan M.W., Gough K., McKnight J.A., Padfield P.L. Ambulatory blood pressure monitoring: is it necessary for routine assessment of hypertension in people with diabetes?. Diabet Med 2002, 19:787-789.
10. Pierdomenico S.D., Lapenna D., Bucci A., Di Tommaso R., Di Mascio R., Manente B.M., et al. Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. Am J Hypertens 2005, 18:1422-1428.
11. Ben-Dov I.Z., Ben-Ishay D., Mekler J., Ben-Arie L., Bursztyn M. Increased prevalence of masked blood pressure elevations in treated diabetic subjects. Arch Intern Med 2007, 167:2139-2142.
12. Sakaguchi K., Horimatsu T., Kishi M., Takeda A., Ohnishi Y., Koike T., et al. Isolated home hypertension in the morning is associated with target organ damage in patients with type 2 diabetes. J Atheroscler Thromb 2005, 12:225-231.
13. Marchesi C., Maresca A.M., Solbiati F., Franzetti I., Laurita E., Nicolini E. Masked hypertension in type 2 diabetes mellitus. relationship with left-ventricular structure and function. Am J Hypertens 2007, 20:1079-1084.
14. Cuspidi C., Meani S., Fusi V., Valerio C., Catinin E., Magrini F., et al. Isolated ambulatory hypertension and changes in target organ damage in treated hypertensive patients. J Hum Hypertens 2005, 19:471-477.
15. Mazze R.S., Robinson R., Simonson G., Idrogo M., Simpson B., Kendall D., et al. Undetected, uncontrolled blood pressure in type 2 diabetes: self-monitored blood pressure profiles. Blood Press 2004, 13:335-346.
16. Leitao C.B., Canani L.H., Kramer C.K., MoehleckeM, Pinto L.C., Ricardo E.D., et al. Blood pressure means rather than nocturnal dipping pattern are related to complications in type 2 diabetic patients. Diabet Med 2008, 25:308-313.
17. Bobrie G., Clerson P., Menard J., Postel-Vinay N., Chatellier G., Plouin P.F. Masked hypertension: a systematic review. J Hypertens 2008, 26:1715-1725.
18. Eguchi K., Ikshikawa J., Hoshide S., Pickering T.G., Shimada K., Kario K. Masked hypertension in diabetes mellitus: a potential risk. J Clin Hypertens 2007, 9:601-607.
19. Obara T., Ohkubo T., Funahashi J., Ikikuya M., Asayama K., Metoki H., et al. The J-HOME Study Group. Isolated uncontrolled hypertension ate home and in the office among treated hypertensive patients from the J-HOME study. J Hypertens 2005, 23:1653-1660.
20. Motz W., Dörr R. ESC/EASD joint guidelines on diabetes and cardiovascular diseases. Herz 2009, 34:21-29.
21. Ormezzano O., Baguet J.P., Francois P., Quesada J.L., Peirre H., Mallion J.M. Is there any real target organ damage associated with white-coat normotension?. Clin Auton Res 2004, 14:160-166.
22. Matsui Y., Eguchi K., Ishikawa J., Hoshide S., Shimada K., Kario K. Subclinical arterial damage in untreated masked hypertensive subjects detected by home pressure measurement. Am J Hypertens 2007, 20:385-391.